Drug intelligence / Profile preview

LETIflem

Development stage: Unknown
Lead developer: Leti Pharma
Modality: Hydrogel Systems → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Administration: Topical

Overview

LETIflem is a specialized dermo-cosmetic topical formulation developed by Laboratorios Leti for the protection and repair of the perioral and nasal skin. It is specifically designed to address skin irritation, redness, and cracking caused by exposure to mucus (phlegm), saliva, and the mechanical friction of tissues, which are common in infants and children during respiratory infections or teething. The product functions by creating a protective physical film that reinforces the skin's natural barrier and incorporates soothing agents to reduce inflammation and promote healing in the affected areas.

Brand names: LETIflem
Other names: LETIflem Perioral Cream

Beyond the preview

Go deeper on LETIflem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LETIflem.

Explore the full profile